Cancer Genomics & Metabolomics

Cancer Genomics & Metabolomics
Malignancy Genomics and Metabolomics. Malignancy genomics is a sub-field of genomics that exemplifies disease connected or malignancy related qualities. Though Metabolomics is the evaluation of little particles framed by metabolic movements inside an organic model. Metabolomics datasets contain an abundance of information that mirror the infection state and are resulting to both hereditary variety and climate. Since malignant growth is a genomic sickness, genomic profiling is an irrefutably significant instrument for accuracy oncology. Accuracy Oncology insinuates the fitting of remedial malignancy treatment to the singular characteristics of each quiet.

  • Cancer Metabolomics
  • Precision Oncology
  • Biomarker Metabolomics
  • Cancer immunotherapy
  • Active immunotherapies

Related Conference of Cancer Genomics & Metabolomics

November 07-08, 2022

5th Annual Conference on Hematologists

Madrid, Spain
February 20-21, 2023

21st World Hematology Congress

Madrid, Spain
February 21-22, 2023

3rd World Congress on Hematology and Genetic Blood Disorders

Zurich, Switzerland

Cancer Genomics & Metabolomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in